Shanghai Cell Therapy Engineering Technology Research Center

Shanghai Cell Therapy Group is a vertically integrated biotechnology company focused on the development and commercialization of innovative cell therapies for cancer. The company operates a comprehensive value chain encompassing cell storage, research and development, and clinical application through its own specialized oncology hospital. Its core technology platform, the Baize Plan, utilizes nanobody-based CAR-T and TCR-T technologies to target both hematological malignancies and challenging solid tumors. With a large-scale GMP manufacturing base in Shanghai, the group aims to provide affordable and effective precision medicine solutions through advanced cell engineering.